Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NSRT to start Phase II trial of Eflornithine granules to treat COVID-19 by early Jan 2021

expresspharmaJanuary 04, 2021

Tag: NSRT , COVID-19 , Eflornithine granules

PharmaSources Customer Service